INNOSPEC INC.

Listed Company

IOSPCIK 0001054905NasdaqLarge AcceleratedChemicals & Allied ProductsDelawareFY ends Dec 31

Period

FY 2025

Revenue

$1.78B

Net Income

$116.60M

Total Assets

$1.83B

Equity

$1.33B

Shares Out

24.63M

Op. Cash Flow

$138.30M

IOSP$84.20−0.95% · past yearDBEQ Basic

Daily closing prices

Business

Innospec develops, manufactures, blends, markets and supplies specialty chemicals globally across three operating segments. Performance Chemicals provides technology-based solutions for personal care, home care, agrochemical, construction, mining and industrial markets. Fuel Specialties manufactures fuel additives that improve fuel efficiency, boost engine performance and reduce emissions for commercial and industrial applications. Oilfield Services supplies chemicals for drilling, completion, production and drag reducing agents for oil and gas exploration and production. The company serves multinational corporations, fuel marketers, oil companies and industrial end-users in the Americas, Europe, the Middle East, Africa and Asia-Pacific.

Summary from 10-K filed 2026-02-18

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net sales	1,778	1,845	1,949	1,964	1,483
Cost of goods sold	−1,286	−1,303	−1,358	−1,377	−1,049
Gross profit	492	543	591	587	435
Selling, general and administrative	−285	−305	−381	−361	−267
Research and development	−51	−57	−49	−39	−37
Adjustment to fair value of contingent consideration	16	−3	0	0	—
Restructuring charge	−900,000	0	0	0	0
Impairment of property, plant and equipment	−23	0	0	—	—
Impairment of intangible assets	−19	0	0	0	0
Profit on disposal of property, plant and equipment	200,000	200,000	0	—	—
Total operating expenses	−363	−365	−430	−399	−303
Operating income	130	178	162	187	132
Other income/(expense), net	−600,000	10	11	−2	4
Pension scheme settlement charge	0	−156	0	0	—
Interest income/(expense), net	9	9	2	−1	−2
Income before income tax expense	138	41	174	185	134
Income tax expense	−22	−6	−35	−52	−41
Net income	117	36	139	133	93
Basic (per share)	4.69	1.43	5.6	5.37	3.78
Diluted (per share)	4.67	1.42	5.56	5.32	3.75
Basic (shares)	25	25	25	25	25
Diluted (shares)	25	25	25	25	25

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2025 2025-07-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Cash and cash equivalents	293	—	289	204	147
Trade and other accounts receivable (less allowances of $11.8 million and $11.9 million, respectively)	342	—	342	360	335
Finished goods	226	—	198	216	259
Raw materials	103	—	103	84	114
Total inventories	329	—	301	300	373
Prepaid expenses	20	—	21	19	14
Prepaid income taxes	13	—	3	3	3
Other current assets	7	—	600,000	600,000	400,000
Total current assets	1,005	—	957	886	873
Net property, plant and equipment	286	—	270	268	221
Operating leases right-of-use assets	53	—	45	45	45
Goodwill	399	2	383	399	359
Other intangible assets	68	—	65	57	45
Deferred tax assets	14	—	9	10	6
Pension asset	0	—	2	35	48
Other non-current assets	9	—	4	6	7
Total assets	1,832	—	1,735	1,707	1,604
Accounts payable	175	—	164	164	165
Accrued liabilities	152	—	169	186	203
Current portion of operating lease liabilities	16	—	14	14	14
Current portion of plant closure provisions	5	—	5	5	5
Current portion of acquisition-related contingent consideration	7	—	0	—	—
Current portion of accrued income taxes	5	—	20	3	18
Total current liabilities	360	—	371	372	406
Operating lease liabilities, net of current portion	37	—	31	32	31
Plant closure provisions, net of current portion	60	—	55	57	52
Deferred tax liabilities	19	—	24	34	26
Pension liabilities and post-employment benefits	13	—	13	13	12
Acquisition-related contingent consideration	1	—	20	23	0
Other non-current liabilities	9	—	4	2	1
Total liabilities	500	—	519	558	563
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares	300,000	—	300,000	300,000	300,000
Additional paid-in capital	377	—	370	361	354
Treasury stock (4,776,918 and 4,594,943 shares at cost, respectively)	−115	—	−93	−94	−95
Retained earnings	1,099	—	1,025	1,028	924
Accumulated other comprehensive loss	−35	—	−91	−148	−145
Total Innospec stockholders' equity	1,326	—	1,211	1,147	1,038
Non-controlling interest	7	—	5	3	2
Total equity	1,333	—	1,216	1,150	1,040
Total liabilities and equity	1,832	—	1,735	1,707	1,604

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	44	44	39	40	43
Adjustment to fair value of contingent consideration	−16	3	0	—	—
Deferred taxes	−10	−39	4	−6	6
Non-cash movements of defined benefit pension plans	3	152	−3	—	—
Stock option compensation	8	9	8	7	4
Trade and other accounts receivable	22	4	−13	−56	−70
Inventories	−7	−12	83	−99	−62
Prepaid expenses	2	−3	−4	5	−4
Accounts payable and accrued liabilities	−33	−5	−27	54	90
Plant closure provisions	−2	900,000	4	1	−1
Accrued income taxes	−22	6	−26	9	−3
Unrecognized tax benefits	0	−15	1	−3	300,000
Other assets and liabilities	−9	4	2	−3	2
Net cash provided by operating activities	138	185	207	82	93
Capital expenditures	−50	−41	−62	−40	−39
Proceeds on disposal of property, plant and equipment	1	500,000	100,000	200,000	3
Business combinations, net of cash acquired	−700,000	−200,000	−35	0	0
Internally developed software	−25	−21	−15	−3	0
Net cash used in investing activities	−75	−62	−112	−42	−36
Non-controlling interest	2	2	0	2	100,000
Repayment of term loan	0	0	−2	0	0
Refinancing costs	0	−300,000	−1	0	0
Dividend paid	−42	−39	−35	−32	−29
Issue of treasury stock	500,000	2	900,000	2	10
Repurchase of common stock	−24	−700,000	−1	−6	−800,000
Net cash used in financing activities	−64	−35	−39	−34	−20
Effect of foreign currency exchange rate changes on cash	4	−2	100,000	−600,000	−500,000
Net change in cash and cash equivalents	3	86	57	5	37

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is INNOSPEC INC.'s CIK number?

INNOSPEC INC.'s SEC CIK number is 0001054905 (1054905). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find INNOSPEC INC.'s SEC filings?

All of INNOSPEC INC.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did INNOSPEC INC. last report earnings?

INNOSPEC INC. (IOSP) most recently filed an earnings 8-K with the SEC on May 8, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001193125-26-213160). This is INNOSPEC INC.'s most recent earnings filing of record — not a forecast of its next earnings date.

What is INNOSPEC INC.'s most recent earnings 8-K?

INNOSPEC INC.'s latest earnings 8-K (Item 2.02) was filed May 8, 2026 under accession 0001193125-26-213160. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View INNOSPEC INC.'s latest earnings 8-K →
Look up any company's CIK number →